Latest profit margin for Panacea Life Sciences Holdings: -2147.67% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
As of the most recent data (June 2026), PLSH shows a profit margin of -2147.67%. That compares with 122.58% in the prior-year period — down 1852.1% year over year. That is below the sector sector average of 13.09%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, PLSH's profit margin is now -2147.67% (was 122.58%) — a 1852.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Panacea Life Sciences Holdings is outperforming or lagging.
The its sector sector average profit margin is about 13.09%. Panacea Life Sciences Holdings is at -2147.67%, which is lower that average. That is roughly 16508.8% below the sector mean. Use the comparison chart on this page to see how PLSH stacks up against individual peers as well.
That compares with 122.58% in the prior-year period — down 1852.1% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Panacea Life Sciences Holdings with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Panacea Life Sciences Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -2147.67%) with ownership activity and broader fundamentals.